Controlled Clinical TrialtaVNS

Vagal nerve stimulation and fibromyalgia: an additional therapeutic option

Dolcini G, Favretti M, Franculli D, Buoncuore G, Pellegrino G, Di Carlo M, Sarzi Puttini P, Conti F, Iannuccelli C, Di Franco M

Clinical and Experimental Rheumatology · 2025

Key finding

After two weeks of treatment, an early reduction in the WPI score (p=0.03) was detected, then confirmed at week 4 (p=0.004).

Condition
Fibromyalgia
Stimulation
taVNS
Evidence tier
Controlled Clinical Trial
Participants
View on DOI

Cite this study

Dolcini, G., Favretti, M., Franculli, D., Buoncuore, G., Pellegrino, G., Di Carlo, M., Sarzi Puttini, P., Conti, F., Iannuccelli, C., & Di Franco, M. (2025). Vagal nerve stimulation and fibromyalgia: an additional therapeutic option. Clinical and Experimental Rheumatology. https://doi.org/10.55563/clinexprheumatol/johqvo

Related studies in Fibromyalgia

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.